These data demonstrate that mortalin depletion can effectively suppresses the viability of PTC, ATC, and FTC tumor lines in culture, possibly via a mechanism selected in a cell type-specific manner. The gene discussed is HSPA9; the disease is thyroid cancer, nonmedullary, 2.